Fady Ibraham Malik - 05 Mar 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
05 Mar 2024
Net transactions value
-$2,011,818
Form type
4
Filing time
05 Mar 2024, 16:05:52 UTC
Previous filing
07 Mar 2024
Next filing
18 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Sale $270,120 -4,000 -2.8% $67.53 138,973 05 Mar 2024 Direct F1
transaction CYTK Common Stock Options Exercise $190,789 +28,604 +21% $6.67* 167,577 05 Mar 2024 Direct F1
transaction CYTK Common Stock Sale $1,932,486 -28,604 -17% $67.56 138,973 05 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -28,604 -50% $0.000000 28,605 05 Mar 2024 Common Stock 28,604 $6.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.